Thermo Fisher's NGS Assay Receives FDA Approval as a Companion Diagnostic for ZEGFROVY and for Tumor Profiling
1. FDA approves Thermo Fisher's Oncomine™ Dx Express Test for tumor profiling. 2. The test enhances decentralized clinical settings with next-gen sequencing capabilities.